Nature Reviews Clinical Oncology
Vol. 22, Issue 9
Issue 9
2025
11
Articles
Articles in this Issue
Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing
Avi Petroff, Ian F. Tannock, Daniel A. Goldstein
Sep 01, 2025
pp. 701-701
10.1038/s41571-025-01063-5
Evolving roles of MET as a therapeutic target in NSCLC and beyond
Jii Bum Lee, Joo Sung Shim, Byoung Chul Cho
Sep 01, 2025
pp. 640-666
10.1038/s41571-025-01051-9
The microbiota in radiotherapy-induced cancer immunosurveillance
Jianzhou Chen, Eric Deutsch, Guido Kroemer et al.
Sep 01, 2025
pp. 667-679
10.1038/s41571-025-01052-8
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro et al.
Sep 01, 2025
pp. 680-700
10.1038/s41571-025-01041-x
A new first-line option for advanced-stage anal squamous cell carcinoma
Diana Romero
Sep 01, 2025
pp. 623-623
10.1038/s41571-025-01056-4
Role of novel immunotherapy combinations in the management of advanced-stage hepatocellular carcinoma
Josep M. Llovet
Sep 01, 2025
pp. 625-626
10.1038/s41571-025-01055-5
Ecological management of the microbiota in patients with cancer
Joao B. Xavier
Sep 01, 2025
pp. 627-639
10.1038/s41571-025-01049-3
From ASCO 2025
Diana Romero
Sep 01, 2025
pp. 624-624
10.1038/s41571-025-01053-7
Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA
David Killock
Sep 01, 2025
pp. 623-623
10.1038/s41571-025-01048-4
Robot-assisted laparoscopic surgery confers improved oncological outcomes
Peter Sidaway
Sep 01, 2025
pp. 623-623
10.1038/s41571-025-01050-w
Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring
Neil Carleton, Priscilla F. McAuliffe
Sep 01, 2025
pp. 621-622
10.1038/s41571-025-01040-y
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English